Amedisys Inc (AMED) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN lifted its stake in Amedisys Inc (NASDAQ:AMED) by 29.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,484,041 shares of the health services provider’s stock after buying an additional 339,825 shares during the period. Wells Fargo & Company MN owned approximately 4.38% of Amedisys worth $83,048,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of AMED. Riverhead Capital Management LLC increased its holdings in shares of Amedisys by 75.5% during the second quarter. Riverhead Capital Management LLC now owns 1,931 shares of the health services provider’s stock worth $121,000 after buying an additional 831 shares in the last quarter. Federated Investors Inc. PA increased its holdings in Amedisys by 2.3% in the second quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 44 shares during the period. Quantitative Systematic Strategies LLC acquired a new stake in Amedisys in the third quarter valued at $205,000. CIBC Asset Management Inc acquired a new stake in Amedisys in the second quarter valued at $230,000. Finally, SG Americas Securities LLC increased its holdings in Amedisys by 48.7% in the second quarter. SG Americas Securities LLC now owns 3,743 shares of the health services provider’s stock valued at $235,000 after purchasing an additional 1,226 shares during the period. Institutional investors and hedge funds own 94.47% of the company’s stock.

A number of brokerages have weighed in on AMED. Benchmark reiterated a “hold” rating on shares of Amedisys in a report on Thursday, November 9th. Robert W. Baird reissued a “hold” rating and set a $50.00 price objective on shares of Amedisys in a research report on Wednesday, October 4th. Mizuho reissued a “buy” rating and set a $65.00 price objective (up previously from $55.00) on shares of Amedisys in a research report on Wednesday, November 8th. Bank of America started coverage on shares of Amedisys in a research report on Monday, August 21st. They issued a “neutral” rating and a $55.00 price target on the stock. Finally, SunTrust Banks reaffirmed a “buy” rating and issued a $70.00 price target on shares of Amedisys in a research report on Friday, November 10th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $61.00.

Shares of Amedisys Inc (NASDAQ:AMED) opened at $54.38 on Friday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.33 and a current ratio of 1.33. Amedisys Inc has a one year low of $39.95 and a one year high of $65.91. The stock has a market cap of $1,861.43, a P/E ratio of 26.24, a PEG ratio of 1.33 and a beta of 0.70.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Tuesday, November 7th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.02. Amedisys had a net margin of 2.88% and a return on equity of 14.68%. The company had revenue of $380.20 million during the quarter, compared to analyst estimates of $384.59 million. During the same quarter last year, the business posted $0.36 EPS. Amedisys’s quarterly revenue was up 5.1% compared to the same quarter last year. research analysts expect that Amedisys Inc will post 2.23 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2017/12/15/amedisys-inc-amed-holdings-increased-by-wells-fargo-company-mn.html.

Amedisys Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply